Listing the High-Profile Clinical Trials For 2023
When it comes to the field of medicine, clinical trials play an important role in advancing our knowledge and improving the way we can provide care to patients. Clinical trials are carefully designed to understand things like whether new drugs and treatments are useful, how safe they are, and the best way to implement them.
While clinical trials are taking place quite regularly, some of them receive more attention than others. This may be due to the nature of the study itself, its impact on the field of medicine, or the researchers involved. Let’s take a look at some of the more high-profile clinical trials for 2023.
Weight Management For Diabetes Patients
One of the most high profile trials is that of New York-based pharma giant, Pfizer and involved weight loss in diabetes patients. When the body develops insulin resistance, it becomes difficult to manage weight since the body converts any available glucose to fat instead of energy.
Pfizer’s study involved 411 Type 2 Diabetes patients who were given danuglipron (the medicine being tested) or a placebo. The results showed that body weight was significantly reduced over the course of 16 weeks.
The drug can be given as an oral treatment and an injection.
Cure for Alzheimer’s
Alzheimer’s has been giving scientists trouble since it was first identified as a problem. While there is still no cure for the disease, an ongoing study is trying to check the effects of CT1812 on Alzheimer’s.
The study involves the prevention and treatment of amyloid beta (Aß) oligomer-induced membrane trafficking deficits - something that has been found to cause early-onset Alzheimer’s.
The trial will have 144 patients with mild to moderate Alzheimer’s, who will be given the drug CT1812 or a placebo. The trial will likely last about 6 months. Previous trials using CT1812 showed that the Aß oligomers can be displaced from neuron receptors, which can make a difference on Alzheimer’s.
Though there is still no way to completely prevent the disease, researchers hope to find ways to prevent any further neurodegeneration in patients. Using sophisticated technology for better clinical data capture may also help with analyzing results more efficiently.
Triple Negative Breast Cancer
Cancer is the second leading cause of death worldwide, right after cardiovascular problems. Naturally, research on preventing cancer is always being carried out, including breast cancer.
Triple negative breast cancer is one of the more challenging forms to treat, since the receptors found on cancer cells - that is, estrogen, progesterone and HER2 - are not expressed.
A phase 2 trial focusing on the use of a combination treatment for these cells using niraparib, dostarlimab and radiation therapy is currently underway.
32 cancer patients in this trial will receive these drugs for 2 years, but the drugs will be withheld if their condition worsens. They will also receive 5 years of follow-ups to ensure that they are safe, and that the combination treatment is working.
Researchers hope this treatment will result in better immune response in cancer patients and keep tumors under control.
Using EDC Systems For Research With Clinical PURSUIT
Clinical data management systems make it easier for researchers to keep track of their observations and findings, and usethem in reporting later on.
Clinical PURSUIT’s EDC systems are top-of-the-line systems used for electronic data capturing and can help you with your research. Visit their website to find out more!

Comments
Post a Comment